Literature DB >> 10848933

Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins.

J J Bergan1, R A Weiss, M P Goldman.   

Abstract

BACKGROUND: Tissue necrosis after sclerotherapy has been observed, but is unexplained.
OBJECTIVE: To present the complication of extensive tissue necrosis following high-concentration sclerotherapy for varicose veins.
METHODS: Cases coming to the attention of the authors are presented briefly with commentary and discussion to explain the mechanisms of tissue destruction.
RESULTS: Although the complication of extensive tissue necrosis has been ascribed to intra-arterial injection, in fact, careful study of the cases described here shows that intravenous injection was present in each case. A theory of distribution of the sclerosant into the arterial arborization is proposed. This theory would explain the distribution of sclerosant into the arterial tree and would also explain the causation of extensive tissue necrosis. Mention is made of experimental work in which intra-arterial injection was not the mechanism of causation of tissue necrosis.
CONCLUSION: Extensive tissue necrosis following high-concentration sclerotherapy may be rare, but its occurrence is serious and its treatment may be incomplete.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848933     DOI: 10.1046/j.1524-4725.2000.00033.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

Review 1.  [Sclerotherapy for varicosities].

Authors:  F Pannier; E Rabe
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

2.  Injection sclerotherapy.

Authors:  Robert L Worthington-Kirsch
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

Review 3.  [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

4.  Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.

Authors:  Matheus Bertanha; Marcone Lima Sobreira; Carlos Eduardo Pinheiro Lúcio Filho; Jamil Victor de Oliveira Mariúba; Rafael Elias Farres Pimenta; Rodrigo Gibin Jaldin; Andrei Moroz; Regina Moura; Hamilton Almeida Rollo; Winston Bonetti Yoshida
Journal:  Trials       Date:  2014-12-19       Impact factor: 2.279

Review 5.  Sclerotherapy in the treatment of varicose veins : S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP.

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-12       Impact factor: 0.751

6.  Atypical leg ulcers after sclerotherapy for treatment of varicose veins: Case reports and literature review.

Authors:  Bibombe P Mwipatayi; Catherine E Western; Jackie Wong; Donna Angel
Journal:  Int J Surg Case Rep       Date:  2016-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.